Impact of BAL lymphocytosis and honeycombing presence on corticosteroid treatment effect in Fibrotic Hypersensitivity Pneumonitis

L. De Sadeleer (Leuven, Belgium), F. Hermans (Leuven, Belgium), E. De Dycker (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), J. Verschakelen (Leuven, Belgium), E. Verbeken (Leuven, Belgium), G. Verleden (Leuven, Belgium), S. Verleden (Leuven, Belgium), W. Wuyts (Leuven, Belgium)

Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. De Sadeleer (Leuven, Belgium), F. Hermans (Leuven, Belgium), E. De Dycker (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), J. Verschakelen (Leuven, Belgium), E. Verbeken (Leuven, Belgium), G. Verleden (Leuven, Belgium), S. Verleden (Leuven, Belgium), W. Wuyts (Leuven, Belgium). Impact of BAL lymphocytosis and honeycombing presence on corticosteroid treatment effect in Fibrotic Hypersensitivity Pneumonitis. 3601

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study
Source: Eur Respir J, 55 (4) 1901983; 10.1183/13993003.01983-2019
Year: 2020



Prognostic impact of bronchoalveolar lavage lymphocytosis in patients with chronic Hypersensitivity Pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Year: 2018



Impact of lymphocyte differential count in BALF on the mortality of patients with acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


The value of lymphocytosis in bronchoalveolar lavage in the differential diagnosis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Work, the environment and respiratory disease
Year: 2011

Proteological assesment of idiopathic pulmonary fibrosis and hypersensitivity pneumonitis by mean of broncho-alveolar lavage
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Induced sputum and BAL from patients with hypersensitivity pneumonitis
Source: Eur Respir J 2001; 18: Suppl. 33, 508s
Year: 2001

Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014

Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018


BAL findings in desquamative interstitial pneumonia (DIP) and other idiopathic interstitial pneumonia (IIP)
Source: International Congress 2014 – ILDs 4
Year: 2014


Markers of treatment outcome in hypersensitivity pneumonitis patients
Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases
Year: 2016

Clinical features and outcomes of patients with diffuse alveolar hemorrhage during antithrombotic therapy
Source: International Congress 2014 – ILDs 5
Year: 2014


Chronic hypersensitivity pneumonitis and its differential diagnosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189
Year: 2007

Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010

Effect of low level laser therapy in a model of pulmonary idiopathic fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Induced sputum in the follow-up of hypersensitivity pneumonitis
Source: Eur Respir J 2001; 18: Suppl. 33, 114s
Year: 2001

Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Hypersensitivity pneumonitis: etiological correlation to bronchoalveolar lavage and functional impairment
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Year: 2020